Equities

Physicians Realty Trust

Physicians Realty Trust

Actions
  • Price (EUR)14.90
  • Today's Change0.70 / 4.93%
  • Shares traded0.00
  • 1 Year change-6.29%
  • Beta--
Data delayed at least 15 minutes, as of Feb 03 2023 07:07 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Physicians Realty Trust (the Trust) is a self-managed real estate investment trust. The Trust, through its operating partnership, Physicians Realty L.P., acquires, develops, owns, and manages health care properties that are leased to physicians, hospitals, and health care delivery systems. The Trust primarily invests in real estate and provides health care services. The Trust's principal investments include medical office buildings (MOBs), ambulatory surgery centers (ASCs), outpatient treatment facilities, and other real estate integral to health care providers. Its properties are located on a campus with a hospital or other health care facilities. The Trust’s portfolio consists of approximately 279 health care properties located in 33 states with approximately 15,591,533 net leasable square feet. Its properties are located in Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maine and others.

  • Revenue in USD (TTM)510.19m
  • Net income in USD120.24m
  • Incorporated2013
  • Employees89.00
  • Location
    Physicians Realty Trust309 N Water St Ste 500MILWAUKEE 53202United StatesUSA
  • Phone+1 (414) 978-6494
  • Websitehttps://www.docreit.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DOC:NYQ since
announced
Transaction
value
Calko Medical Center,Brooklyn,NYDeal completed13 Sep 202213 Sep 2022Deal completed-8.24%81.50m
Data delayed at least 15 minutes, as of Feb 03 2023 21:10 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.